View on Pubmed.gov 35934552 | View on doi.org 10.1016/j.blre....
Complement activation in COVID-19 and targeted therapeutic options: A scoping review.
- Amsterdam UMC location University of Amsterdam, Department of Intensive Care Medicine, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam UMC Location University of Amsterdam, Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Amsterdam, the Netherlands; Amsterdam UMC location University of Amsterdam, Department of Neurology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Neuroscience, Amsterdam, the Netherlands.
- Amsterdam UMC location University of Amsterdam, Department of Intensive Care Medicine, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam UMC Location University of Amsterdam, Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Amsterdam, the Netherlands.
- Amsterdam UMC location University of Amsterdam, Department of Intensive Care Medicine, Meibergdreef 9, Amsterdam, the Netherlands.
- Amsterdam UMC location University of Amsterdam, Department of Intensive Care Medicine, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, the Netherlands.
- Amsterdam UMC location University of Amsterdam, Department of Neurology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Neuroscience, Amsterdam, the Netherlands.
- Amsterdam UMC location University of Amsterdam, Department of Intensive Care Medicine, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam UMC Location University of Amsterdam, Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Amsterdam, the Netherlands. Electronic address: a.p.vlaar@amsterdamumc.nl.
Abstract
Increasing evidence suggests that activation of the complement system plays a key role in the pathogenesis and disease severity of Coronavirus disease 2019 (COVID-19). We used a systematic approach to create an overview of complement activation in COVID-19 based on histopathological, preclinical, multiomics, observational and clinical interventional studies. A total of 1801 articles from PubMed, EMBASE and Cochrane was screened of which 157 articles were included in this scoping review. Histopathological, preclinical, multiomics and observational studies showed apparent complement activation through all three complement pathways and a correlation with disease severity and mortality. The complement system was targeted at different levels in COVID-19, of which C5 and C5a inhibition seem most promising. Adequately powered, double blind RCTs are necessary in order to further investigate the effect of targeting the complement system in COVID-19.
References
Front Immunol. 2021 Mar 25;12:663187
Clin Immunol. 2021 Jun;227:108733
Front Immunol. 2021 Nov 24;12:700705
N Engl J Med. 2021 Feb 25;384(8):693-704
Cited by 50 citations (total)
Journal Article Review
Pathophysiological mechanisms of thrombosis in acute and long COVID-19.
Electronic publication date December 6, 2022
Haijiao Jing [...] Jialan Shi et al.
COVID-19 patients have a high incidence of thrombosis, and thromboembolic complications are associated with severe COVID-19 and high mortality. COVID-19...
Journal Article Review
Global impact of proteoglycan science on human diseases.
Electronic publication date October 23, 2023
Christopher Xie [...] Renato V Iozzo et al.
In this comprehensive review, we will dissect the impact of research on proteoglycans focusing on recent developments involved in their...
Conflict of interest statement
Declaration of Competing Interest Prof. Vlaar reports personal fees from InflaRx paid to Amsterdam UMC, outside the submitted work. All other authors declare no competing interests.
MeSH
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •
Copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.